1. (1) Except as otherwise authorized or in applicable state and federal statutes or regulations, psychotropic medications shall not be administered to a patient unless the patient has given informed consent in writing. A change of dosage or medication within a class does not require obtaining a new consent, but the patient shall be informed of such change and shall be provided an explanation for the change, and this shall be documented in the record. PSYCHOTROPIC MEDICATIONS AT MENTAL HEALTH INSTITUTES Informed consent for psychotropic medication includes consent for procedures associated with the safety and efficacy of psychotropic medication management, such as periodic lab work.
2. (2) Except as otherwise authorized or in applicable state and federal statutes or regulations, physical treatment, including medication, shall not be administered to a patient unless the patient or patient’s legal representative has given informed consent in writing. Informed consent for physical treatment includes consent for procedures associated with the safety and efficacy of the physical treatment, such as periodic lab work.
3. (3) Except as otherwise authorized or in applicable state and federal statutes or regulations, healthcare information relating to a patient shall not be released to a person or organization unless the patient or patient’s legal representative has given informed consent in writing.
4. (4) Each RMHI shall have an informed consent policy that delineates which treatments/services require informed consent and which treatments/services do not require informed consent.

Authority: T.C.A. §§ 33-1-302 through 33-1-305, 33-3-104, 33-6-107, and 33-6-1006. Administrative History: (For Administrative History prior to February, 1985 see page 1.001). New rule filed January 9, 1985; effective February 8, 1985. Amendments filed December 22, 2025; effective March 22, 2026.